Searched for
DRUG PRICING TRANSPARENCY
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...
- The old health insurance model sees hospitalisation as an inconvenience, says Narayana Health's Viren Prasad Shetty; bets on managed care modelIt has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Vijay sworn in as Tamil Nadu CM: Here's what TVK promised ahead of Assembly pollsTamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...
- Thailand eyes a new rule that could change your travel plansThailand plans to implement compulsory health insurance for all foreign visitors, including tourists and workers, to mitigate unpaid medica...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- US debt crisis: Mark Cuban warns America’s $38 trillion debt is tied to broken healthcare pricing - here’s his solutionMark Cuban warns about US debt crisis: Cuban argues that overhauling healthcare, particularly insurance and drug pricing, can significantly...
- Gilead adds ten new countries for Sovaldi access programmeGilead said that it has also updated the pricing structure for drugs that it will be selling through its partner.
- Eli Lilly unhappy with National Pharmaceutical Pricing Authority, calls for consultative approachOlaizola, however, said the company is "working to ensure we comply with all orders issued by the NPPA regarding pricing of medicines."
- Government plans to replace DPCO with a new legislationAs per the new drugs policy, all strengths and dosages specified in the National List of Essential Medicines (NLEM) 2011 will be under pric...
- Robust IT architecture holds key to making government's new healthcare plan effective: Kiran Mazumdar ShawIndia's per capita public spending on health is an abysmal $32 or about Rs 1,800 per annum. The neediest of patients are often denied drugs...
- AIOCD for drug pricing on median price with over 1% mkt shareWelcoming the government's draft proposal on drug pricing policy, the chemist body said the Centre should also decide the weighted average ...
- New drug-pricing policy to determine prices at which firms can sell essential medicines in marketThe National Pharmaceutical Pricing Policy, 2011, seeks to evolve a formula to fix the maximum retail prices of 348 essential drugs.
- AIDAN proposes another pricing model for essential drugsA non-govt organisation campaigning for cheaper essential drugs has proposed an alternative pricing model that seeks to fix retail prices a...
- NPPA to get more punchDrug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to become stronger, more transparent and receptive to industry...
- Govt to impose excise duty on drugsJustifying government's decision to impose excise duty on medicines based on maxium retail price, PC said this would ensure transparency in...
Load More
